• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Genentech, a Member of the Roche Group

Monday, June 03, 2024
CP
Multiple Therapeutics
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. Today, as a member of the Roche Group, we remain dedicated to pursuing breakthrough research, developing life-changing medicines, unlocking advances in data and technology, and partnering across society to take on systemic issues that stand in the way of better healthcare for all. We lead change in our industry and advance science for the greater good. We embrace diversity and inclusion to drive innovation, improve outcomes, and create more equitable healthcare access. And every day, we lean into the biggest challenges in science, medicine, technology, and beyond to deliver patient-centered healthcare that improves life for every person.
Genentech, a Member of the Roche Group
Company Website: http://gene.com
Lead Product in Development: Ocrevus

Exchange

SIX Swiss Exchange

Ticker

RHHBY

Company HQ City

South San Francisco

Company HQ State

California

Company HQ Country

United States

CEO/Top Company Official

Ashley Magargee

Development Phase of Primary Product

Multiple Products in Market
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS